CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Clinical trial NCT02061800 · UNKNOWN

Trial details

NCT number: NCT02061800
Sponsor: Diane George
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Myeloid Leukemia (CML)Acute Myelogenous Leukemia (AML)Myelodysplastic Syndrome (MDS)Juvenile Myelomonocytic Leukemia (JMML)Acute Lymphoblastic Leukemia (ALL)Lymphoma (Hodgkin's and Non-Hodgkin's)

Start date: 2013-06-03
Primary completion: 2026-07-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.